In a competition with many excellent projects, and, as a result of the 2nd phase evaluation of Coordination and Support Actions for FET Flagships, Health EU was recognized as the leading project on Human Avatars and Digital Healthcare and is currently in a potential position for future funding.
Health EU management is looking with strong conviction into a bright future of a European mission on creating the first European Integrative Human Avatar Platform under the umbrella of Digital Healthcare enabled by Artificial Intelligence and Internet of Things.
Today, we launch the Health EU Manifesto to unify all forces in medicine, biology, social sciences and engineering Europe under the visionary concept of Human Avatars for personalized, preventive and participatory healthcare. We invite all interested universities, research institutes, hospitals, industries and citizen/patient associations and other stakeholders to sign our Manifesto as an expression of direct support!
Meet us in Dortmund, Germany: Prof. Adrian Ionescu will give a keynote at the 8th NRW Nano-Conference, on November 21st: http://nanoconference.de/the-keynotes/
Following a keynote presentation at the European Integrative Technology Platform of Health EU at IOOCS 2018 (https://www.ioocs18.com/home, November 9th, 2018, Eindhoven, The Netherlands), by professor Adrian Ionescu, and a Meet the Expert networking session, the brand-new European Organ-on-Chip Society decided to enthusiastically support Health EU in the quest of revolutionizing personalized, preventive and participatory healthcare in Europe. This extraordinary support creates an unified framework for Health EU to federate all European research in Organ-On-Chip to advance towards the goals of building a Human Avatar for every European citizen.
Health EU will be present at the RTO innovation summit that will take place in Brussels on 6-7 Nov 2018, co-organised by 10 Research & Technology Organisations. Prof. Albert van den Berg will present our proposal in the session Health: Tools and Technologies for Health & Care (6 Nov, 17:00 to 18:15) and will be happy to answer all your questions!
Prof. Albert van den Berg gave a TedTalk on “Health EU: Unifying Initiative for the Future of Healthcare in Europe” in Brussels on October 10th, at the European week of Regions and Cities, on Future of Healthcare in Europe.
To quote Prof. van den Berg: "In 20 years from now, having a Human Avatar to monitor your health will be the norm. We invite all stakeholders to join us in this development."
Patrick Boisseau, Deputy Head of Division, European Affairs at CEA-LETI and member of the Health EU steering board, presented the Health EU Flagship approach today at the CEO Summit 2018 in Brussels. The audience composed of 60+ industrial leaders in medtech and diagnostics companies was delighted about this foresight looking lecture. Some interesting questions about ethical and societal issues related to avatars or “when will it be available” gave rise for discussion and some very positive feedback was received during the coffee breaks.
Patrick Boisseau, Deputy Head of Division, European Affairs at CEA-LETI and Chairman of the ETPN, presented Health EU Flagship approach at ETPN 2018, Berlin, Germany, in a talk entitled: ''Human avatars to prevent and cure diseases Health EU vision for a sustainable future of the European healthcare'', attracting significant support and high interest from the audience for the Health EU Flagship.
Both of the EPFL projects that applied for the European Commission’s FET Flagship programme have successfully cleared the first hurdle. These projects are the Time Machine, headed by Frédéric Kaplan at the Digital Humanities Laboratory, and Health EU, run by Adrian Ionescu at the Nanoelectronic Devices Laboratory (Nanolab). If selected, they will receive one billion euros over ten years as part of the European Commission’s ambitious funding programme.
With Health EU, everyone will one day have their own medical avatar – a virtual replica of themselves featuring their own personal data – that could improve the way their health is managed and the treatments they are given. This international project, led by a consortium headed by EPFL and the University of Twente, aims to achieve enhanced disease prevention, early diagnosis, more accurate monitoring and customized, targeted administration of medicines and treatments, especially for increasingly common diseases such as cancer and cardiovascular, chronic and neurodegenerative disorders.
The Time Machine is based on the Venice Time Machine (VTM), a project that started in 2012 and served as a proof of concept. The VTM aimed to build a multidimensional model of the city that spans the past millennium, using millions of historical documents stored in a variety of formats. After five years, the project team has scanned 190,000 records from the Venice State Archive along with 720,000 photographs and 3,000 books on Venice’s history. The objective of the Time Machine is to replicate the VTM across Europe. It will create a large-scale simulator for mapping 2,000 years of European history and turning the huge archives and sizeable museum collections into one big digital information system.
A total of 33 projects from universities across Europe have applied for the programme, which is intended to support future and emerging technologies (FET). Only 17 of them – just over half – were selected for the second round, scheduled to end on 18 September 2018.EPFL also plays a key role in a third project in the running for a FET Flagship, Robotics Flagship, which made it through to the second round as well.
The full EPFL press release including more information about the proposals you can find here.
Professor Ben Feringa, who won the 2016 Nobel Prize in chemistry for the development of molecular machines, expresses his appreciation of the Health EU proposal: “This is a very ambitious programme that combines modern science and technology to create new opportunities for the future of healthcare and keep it affordable.”
Professor Feringa is a pioneer in the field of molecular engines, catalysis and smart medication.